RecallDepth
Class II Terminated

Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017

Company
Pfizer Inc.
Recall Initiated
April 22, 2022
Posted
May 25, 2022
Recall Number
D-0873-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
10,304 bottles
Firm Location
New York, NY, United States

Reason for Recall

CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lots: DX8682 Exp. MAR 31 2023; DG1188 Exp. MAR 31 2022

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class II Drug recalls